Skip to main content
. 2021 Jun 11;12:678563. doi: 10.3389/fmicb.2021.678563

TABLE 5.

Occurrence of mutations observed following experimental passages in naturally occurring IBDV genomes.

IBDV segment Viral protein aasubstitutiona Virus stock number ofsamples where the substitution was found/total Other IBDVstrains with similar residuesb
A VP5 Ser7Gly rvv-p12 1/3 Faragher 52/70 (cv, HG974565.1); USC2003 (vv, KU183665.1); USC2010 (vv, KU183667.1)
VP5 His63Tyr rCu-1-p12/DF-1/7DMA 1/3 23/82 (serotype II, Z21971.1)
VP5 Ile74Phe rCu-1-p12/B 1/3 Phenylalanine conserved in vvIBDV strains
VP5 Thr131Ala rCu-1-p12/DF-1 1/3 GX-NNZ-11 (vv, JX134483.1)
VP5 Arg133Trp rCu-1-p12/B/7DMA 1/3 Tryptophane conserved in vvIBDV strains
VP2 *Pro222Leu rCu-1-p12/B 1/3 160019 (reassortant isolate, KY610529.1)
VP2 Gln249Arg rCu-1-p12/DF-1 1/3 IC-IBDV-Br (KC603937.1); P2 (cv, X84034.1); Gt (cv, DQ403248.1)
VP2 *Ala270Glu rvv-p12 3/3 UPM94/273 (vv, AF527039.1); OH (serotype II, U30818.1)
VP2 *Ala270Thr rvv-p12/7DMA 3/3 Threonine highly conserved in cvIBDV strains
VP4 *Cys680Tyr rCu-1-p12/B, rCu-1-p12/B/7DMA, rCu-1-p12/DF-1, rCu-1-p12/DF-1/7DMA 8/12 Tyrosine highly conserved in vvIBDV strains
VP4 Cys680Arg rCu-1-p12/B 1/3 23/82 (serotype II, Z21971.1)
VP4 *Ala713Thr rCu-1-p5/ch, rCu-1-p12/B, rCu-1-p12/B/7DMA 4/7 Threonine presents in all sequences analyzed
VP4 Tyr741His rvv-p12, rvv-p12/7DMA 4/6 100056 (reassortant isolate, KU234528.1)
B VP1 *Thr329Ala rvv-p12/7DMA, rCu-1-p12/B/7DMA, rCu-1-p12/DF-1/7DMA 9/9 IBD13HeB01 (reassortant isolate, AKD94180.1)
VP1 Val865Ala rCu-1-p12/B/7DMA, rCu-1-p12/DF-1/7DMA 2/6 HBDY-1 (KX592159.1); OH (serotype II, U30819.1)

aAmino acid (aa) substitution indicated using numbering of VP5 ORF, polyprotein or VP1 ORF. bThe IBDV classification belonging to serotype I [classical virulent (cv); very virulent (vv)], serotype II or defined as a reassortant isolate was indicated when it was possible. In brackets, Genbank accession numbers. *Dominant mutations.